Skip to main content
Top
Literature
2.
go back to reference Beutler E (1990) The genetics of glucose-6-phosphate dehydrogense deficiency. Semin Hematol 27:137–164PubMed Beutler E (1990) The genetics of glucose-6-phosphate dehydrogense deficiency. Semin Hematol 27:137–164PubMed
3.
go back to reference Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E (2012) Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations. Blood Cells Mol Dis 48:154–165CrossRefPubMed Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E (2012) Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations. Blood Cells Mol Dis 48:154–165CrossRefPubMed
4.
go back to reference Au SWN, Gover S, Lam VMS, Adams MJ (2000) Human glucose-6- phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency. Struct Fold Des 8:293–303CrossRef Au SWN, Gover S, Lam VMS, Adams MJ (2000) Human glucose-6- phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency. Struct Fold Des 8:293–303CrossRef
Metadata
Title
A Novel G6PD p. Gly 321 Val Mutation Causing Severe Hemolysis in an Indian Infant
Authors
R. Devendra
P. Warang
V. Gupta
A. Chiddarwar
P. Kedar
M. B. Agarwal
M. B. Mukherjee
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1049-3

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine